Prasugrel reduces ischaemic infarct volume and ameliorates neurological deficits in a non-human primate model of middle cerebral artery thrombosis
Atsuyuki Tomizawa(Daiichi-Sankyo (Japan)), Atsuhiro Sugidachi(Daiichi Sankyo (United Kingdom)), Makoto Mizuno(The University of Tokyo), Kousaku Ohno(Sanin Rosai Hospital), Joseph A. Jakubowski(Indiana Biosciences Research Institute)
Cited by 17
Related Papers
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention
|Circulation|2007|882
Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes
|New England Journal of Medicine|2013|651
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents
|Journal of the American College of Cardiology|2012|617